KPTI · ISSUER CIK 1503802
Karyopharm Therapeutics Inc.
Between Aug 1, 2026 and Oct 29, 2026, 1 Karyopharm Therapeutics Inc. insiders reported $0.00 of open-market purchases and $2K of sales on SEC Form 4.
↗1 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 0 of 3 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$2KInsider selling
−$2KNet open-market
Oct 19, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 19, 202616:03 | Oct 16, 2026 | KPTI | Chief Accounting Officer | S · Sell | $0.34 | −4,788 | 18,616 | -20% | −$2K | ||
| Oct 2, 202616:01 | Oct 1, 2026 | KPTI | Chief Accounting Officer | S · Sell | $1.19 | −378 | 23,404 | -2% | −$449.82 | ||
| Sep 2, 202616:57 | Sep 1, 2026 | KPTI | Chief Accounting Officer | S · Sell | $2.02 | −19 | 23,782 | -0% | −$38.38 |